LENZ Therapeutics GAAP EPS of -$0.99 misses by $0.04, revenue of $3.38M misses by $0.82M

Nigeria South Africa Ghana Senegal Uganda Kenya Morocco Egypt Tanzania Zimbabwe Algeria Sudan Ethiopia Ivory Coast Libya Somalia Tunisia Mozambique Zambia DR Congo Angola

India Iran Malaysia Japan Pakistan Indonesia China Turkey South Korea Israel Philippines Saudi Arabia United Arab Emirates Bangladesh Singapore Cambodia Thailand Vietnam Yemen Palestine Nepal North Korea Taiwan Iraq Kazakhstan Syria Lebanon Qatar Afghanistan Sri Lanka Jordan Uzbekistan Kuwait Laos

United Kingdom Russia France Italy Spain Germany Ukraine Poland Portugal Ireland Netherlands Greece Belgium Austria Finland Romania Switzerland Denmark Czech Republic Hungary Sweden Norway Serbia Croatia Bulgaria Georgia Belarus Slovakia Slovenia Iceland

United States Mexico Canada Dominican Republic Costa Rica Guatemala Honduras Puerto Rico Jamaica Cuba Panama Belize Nicaragua El Salvador Haiti Bahamas Trinidad and Tobago Barbados

Brazil Peru Colombia Ecuador Argentina Venezuela Bolivia Uruguay Chile Paraguay

Australia New Zealand Papua New Guinea Fiji